Enoxaparin 40mg per day is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgery.

CONCLUSIONS: Enoxaparin 40mg once daily is inadequate for the majority of thoracic surgery inpatients, based on a pharmacodynamic study of aFXa levels. Future research should examine the impact of weight based once daily enoxaparin dosing versus twice daily enoxaparin dosing on prophylaxis adequacy.
PMID: 29626461 [PubMed - as supplied by publisher]

Source: The Annals of Thoracic Surgery - April 4, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Pannucci CJ, Fleming KI, Holoyda K, Moulton L, Prazak AM, Varghese TK Tags: Ann Thorac Surg Source Type: research